Unaudited Pro Forma Condensed Combined Financial Information
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001193125-23-205104
- Document
- 8-K
- Exhibit 4.2
- Warrants or notes
- Exhibit 4.3
- Warrants or notes
- Exhibit 4.4
- Warrants or notes
- Exhibit 10.5
- Material contract
- Exhibit 10.10
- Material contract
- Exhibit 10.11
- Material contract
- Exhibit 10.13
- Material contract
- Exhibit 10.18
- Material contract
- Exhibit 10.25
- Material contract
- Exhibit 10.27
- Material contract
- Exhibit 10.28
- Material contract
- Exhibit 10.29
- Material contract
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Completes an acquisition or sale of assets (2.01)
- Takes on a new financial obligation (2.03)
- Sells unregistered shares (3.02)
- Changes shareholder rights (3.03)
- Reports a change in control (5.01)
- Reports an executive or board change (5.02)
- Amends its charter or bylaws (5.03)
- Changes its ethics code (5.05)
- Changes its shell company status (5.06)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Neuraxis NRXS public float $20M, Jun 30, 2025
- Positron POSC public float $22M, Jun 30, 2025
- Dror Ortho-Design DROR public float $19M, Jun 30, 2025
- Vivos Therapeutics VVOS public float $23M, Jun 30, 2025
- United Health Products UEEC public float $25M, Jun 30, 2025